|
|
||||||||
Eur J Cardiothorac Surg 2001;20:437-442
© 2001 Elsevier Science NL
Thoracic Surgery Unit, Department of Surgery, S. Maria delle Croci Hospital, Viale Randi, 5, 48100 Ravenna, Italy
Received 21 November 2000; received in revised form 7 March 2001; accepted 6 June 2001.
Corresponding author. Tel.: +39-0544-285473; fax: +39-0544-285722
e-mail: lsolaini{at}libero.it
| Abstract |
|---|
|
|
|---|
Key Words: Video-assisted thoracic surgery Pulmonary lobectomy VATS lobectomy
| 1. Introduction |
|---|
|
|
|---|
The purpose of this report is to present our findings on 125 cases of VATS major pulmonary resections in order to contribute towards a clearer definition of the related problems, with particular reference to the indications, perioperative results and long-term outcomes.
| 2. Materials and methods |
|---|
|
|
|---|
All the patients were examined with chest X-ray, computed tomography (CT) scan and bronchoscopy with transbronchial biopsy; in cases in which no histological diagnosis was available, a transcutaneous biopsy was performed. In 20 of these cases no diagnosis was obtained and for these patients the indication for surgery was therefore of an indeterminate nodule. In these cases, a videothoracoscopic pulmonary wedge resection was initially carried out and when the frozen section revealed the presence of a lesion for which a lobectomy was required, this was performed during the same surgical session. In just two of these cases, in which the indeterminate nodule was located at the hilum of the middle lobe, the lobectomy was directly performed.
The indications for VATS lobectomy are shown in Table 1. In addition to the 100 cases of stage I non-small cell lung cancer (NSCLC), there were 11 patients with solitary metastasis that could not be excised with a wedge resection due to the proximity of the lesion to the hilum. An indication for VATS for typical carcinoids, discussed in detail in an earlier report [14], was ascertained in seven cases for peripheral nodules and in five cases for central lesions, of which one was located at the bifurcation of the intermediate bronchus and the others at the branch of a lobar or segmental bronchus. The indication for VATS was based on a careful examination of the CT scan: the lesion must be no greater than 4 cm in diameter, it must not infiltrate the thoracic wall, the mediastinum or the diaphragm and no hilar or mediastinal lymph nodes should be greater than 1 cm in diameter. However, in five patients with pulmonary carcinoma, in which the CT scan had revealed larger peritracheal nodes, a mediastinoscopy was carried out that identified the adenopathies as benign. Moreover, only in the cases of carcinoma, the lesion should not be visible in the lobar or segmental bronchi during bronchoscopic examination. With regard to further preoperative tests and preparation for the operation, there were no variations from the standard criteria for traditional surgical pulmonary resection.
|
The surgical technique (Fig. 1 ) applied is now standard and is similar to that proposed by Roviaro et al. [1,4] and briefly described in a previous report [15]. We use three ports and an anterior mini thoracotomy no greater than 5 cm in length without spreading the ribs; all the broncho-vascular structures are separately isolated and divided.
|
Probability of survival after VATS lobectomy was estimated by the KaplanMeier method. The influence of variables on survival (univariate analysis) was analyzed using the log-rank test; values of P<0.05 were considered significant.
| 3. Results |
|---|
|
|
|---|
|
In the patients with NSCLC, mediastinal lymph node dissection was carried out in 22 cases and sampling was performed in 62 cases, whereas in three cases, which were the first VATS lobectomies to be performed, the lymph nodes were not considered. In patients with typical carcinoids, only lymph node sampling was performed, whereas in those with solitary metastases and in those with benign pathology, the mediastinal lymph nodes were not removed.
The amount of time required for the procedure diminished with the increase in experience; whereas the first operations took five hours, the later operations took no more than 2.5 h, even in complicated cases.
Postoperative stay was uneventful in 99 (88.4%) of the 112 patients undergoing operations that were completed by VATS and in all 13 cases in which thoracotomy was necessary. The mean length of postoperative stay was 6.2 days (range: 421 days) but in the 98 patients undergoing lobectomy or bilobectomy with no complications, it was 5.8 days (range: 48 days). Postoperative complications arose in 13 cases (11.6%) with one of these requiring a subsequent operation. This patient, treated for a carcinoid, had a haemothorax requiring transfusion 12 h after the procedure; during the re-operation, also carried out by VATS, the source of the haemorrhage was not identified. In spite of this complication he was discharged 7 days after the operation. Seven patients presented air leaks: five of these were prolonged and associated with subatelectasis of the residual lobe, whereas two were revealed by a large mediastinal and subcutaneous emphysema. In a period of 1121 days after surgery all these air leaks were completely resolved. Moreover, two patients had pneumonia that was treated with antibiotics recovering 13 and 16 days after the operation. The two remaining patients presented atrial fibrillation treated with amiodarone and one presented urinary retention that was treated with a fixed urinary catheter.
The definitive pathological finding of the pulmonary lesions and the postoperative staging of the primary carcinomas are shown in Table 3. With regard to the anatomopathological examination, it should be mentioned that in seven cases during the extraction of the specimen from the thoracic cavity a laceration of the tumour and the surrounding parenchyma occurred; as a result it was difficult to measure the exact size of the tumour and to identify the T for the TNM staging with any precision. Consequently, among the group of 72 cases of stage I NSCLC, we undoubtedly had 41 T1 and 24 T2. Moreover, in the same group of patients we found 37 squamous carcinomas and 35 adenocarcinomas.
|
|
|
|
|
| 4. Discussion and conclusions |
|---|
|
|
|---|
The rate of conversion to thoracotomy reported in the literature (Table 4) ranges from 0 [6] to 26.8% [18]. This is mainly due to oncological factors, as there are many cases in which preoperative staging is underestimated with the result that the operation cannot be continued endoscopically. The second cause is bleeding which, especially in the early cases, results in the need to convert to thoracotomy, at times very rapidly; in this connection, however, it must be stressed that there do not appear to be any cases of mortality due to bleeding of this kind in the literature. Except in the case of serious mistakes during dissection or malfunctioning of an endostapler [19], haemorrhages are always easily brought under control by the application of pressure or the closure of the vessel with endoscopic pincers; subsequently, a decision must be taken about whether to proceed by means of thoracotomy. Another frequent cause of the conversion to thoracotomy is that of adhesion preventing proper dissection of the broncho-vascular structures of the hilum.
|
The results of follow-up studies of patients undergoing VATS lobectomy for cancer do not seem to vary greatly from those obtained for open surgery: Lewis et al. [6], in a report of 100 cases with a mean follow-up of 26.5 months, found six cases of recurring neoplasia, whereas McKenna et al. [11], with a mean follow-up of 28.9 months, report a survival rate 4 years after operation of 70% for stage I NSCLC. Kirby et al. [20], who compared the results for a group of VATS lobectomies with those for a group of thoracotomies did not report any significant differences in survival rates 13 months after the operation; in a prospective study, Sugi et al. [13] reported in 100 cases of stage 1A NSCLC a 5-year survival rate of 90% for VATS and 85% for thoracotomy. Our long-term results show a 3-year survival rate of 90% for stage I pulmonary carcinoma and therefore they are similar to the previous studies. We believe that all these good results of VATS lobectomy will have to be confirmed by large series, but at present they seem not to significantly differ from those achieved by open surgery.
The main criticism regarding the use of VATS in major pulmonary resection concerns the indications for this type of treatment, with particular reference to compliance with the principles of oncological surgery in neoplastic patients. In order to make a careful selection it is important to assess the position and size of the tumour, in order to operate only on stage I patients, preferably with squamous type [23] and in a peripheral part of the lung. This assessment is carried out on the basis of CT scan and bronchoscopy: the tumour must be no greater than 4 cm in diameter, must be within the parenchyma and must not be visible during bronchoscopy. Unlike other authors [6,11], we believe that lesions of a larger size should not be treated by VATS due to the objective difficulty of the endoscopic movements and the high probability that such tumours are at an advanced stage. On the basis of these considerations it may be stated that though pneumonectomies can be carried out by VATS, they are only indicated in isolated cases. Moreover, CT scan should not show enlarged hilar or mediastinal lymph nodes, which would give rise to problems in identifying arterial and bronchial branches during endoscopic surgery or would spread from the cancer. The presence of enlarged lymph nodes only in the mediastinum is not a contraindication, but it should first be investigated by mediastinoscopy. In agreement with other authors [7,11,13,23,24], we are of the opinion that with VATS it is possible to carry out a complete pulmonary resection with an adequate surgical staging of the tumour. In order to assess the mediastinal lymph nodes, we prefer to perform sampling, as we do in conventional surgery, even if complete lymphadenectomy can be done by VATS [7,23,24].
In conclusion, we believe that VATS could be the preferred method to perform lobectomy in the treatment of selected cases of pulmonary lesions including stage I NSCLC. It seems to produce the same results over time as open surgery, but it has the advantages of being minimally invasive. However, VATS lobectomy must be used only with precise indications, since it is a relatively complex procedure; there is a need to select patients carefully for this technique and to convert to thoracotomy in cases in which the anatomical and pathological conditions are not suitable.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. A. Whitson, S. S. Groth, S. J. Duval, S. J. Swanson, and M. A. Maddaus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review of the Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Approaches to Lobectomy Ann. Thorac. Surg., December 1, 2008; 86(6): 2008 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Reed, M. W. Lucia, S. L. Starnes, W. H. Merrill, and J. A. Howington Thoracoscopic lobectomy: introduction of a new technique into a thoracic surgery training program. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 376 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Nicastri, J. P. Wisnivesky, V. R. Litle, J. Yun, C. Chin, F. R. Dembitzer, and S. J. Swanson Thoracoscopic lobectomy: Report on safety, discharge independence, pain, and chemotherapy tolerance J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 642 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Shaw, F. R. Dembitzer, J. P. Wisnivesky, V. R. Litle, T. S. Weiser, J. Yun, C. Chin, and S. J. Swanson Video-Assisted Thoracoscopic Lobectomy: State of the Art and Future Directions Ann. Thorac. Surg., February 1, 2008; 85(2): S705 - S709. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Flores and N. Alam Video-Assisted Thoracic Surgery Lobectomy (VATS), Open Thoracotomy, and the Robot for Lung Cancer Ann. Thorac. Surg., February 1, 2008; 85(2): S710 - S715. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Demmy and C. Nwogu Is Video-Assisted Thoracic Surgery Lobectomy Better? Quality of Life Considerations Ann. Thorac. Surg., February 1, 2008; 85(2): S719 - S728. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Solli and L. Spaggiari Indications and Developments of Video-Assisted Thoracic Surgery in the Treatment of Lung Cancer Oncologist, October 1, 2007; 12(10): 1205 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Scott, J. Howington, S. Feigenberg, B. Movsas, and K. Pisters Treatment of Non-small Cell Lung Cancer Stage I and Stage II: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 234S - 242S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. West, S. Rashid, and J. Dunning Does video-assisted thoracoscopic lobectomy produce equal cancer clearance compared to open lobectomy for non-small cell carcinoma of the lung? Interactive CardioVascular and Thoracic Surgery, February 1, 2007; 6(1): 110 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. McKenna Jr, W. Houck, and C. B. Fuller Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases Ann. Thorac. Surg., February 1, 2006; 81(2): 421 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Booton, M Jones, and N Thatcher Lung cancer * 7: Management of lung cancer in elderly patients Thorax, August 1, 2003; 58(8): 711 - 720. [Full Text] [PDF] |
||||
![]() |
L. J. Daniels, S. S. Balderson, M. W. Onaitis, and T. A. D'Amico Thoracoscopic lobectomy: a safe and effective strategy for patients with stage i lung cancer Ann. Thorac. Surg., September 1, 2002; 74(3): 860 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P.C. Yim VATS major pulmonary resection revisited--controversies, techniques, and results Ann. Thorac. Surg., August 1, 2002; 74(2): 615 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Thomas, C. Doddoli, S. Yena, X. Thirion, F. Sebag, P. Fuentes, and R. Giudicelli VATS is an adequate oncological operation for stage I non-small cell lung cancer Eur. J. Cardiothorac. Surg., June 1, 2002; 21(6): 1094 - 1099. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |